Zenas BioPharma (ZBIO) Other Working Capital Changes (2023 - 2026)
Zenas BioPharma (ZBIO) recorded quarterly Other Working Capital Changes of $6.5 million in Q1 2026, up 2745.71% quarter-over-quarter from -$245000.0 in Q4 2025, and up 3019.82% on a YoY basis from $207768.4 in Q1 2025.
Zenas BioPharma (ZBIO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Zenas BioPharma's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $6.5 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 3019.82% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $5.8 million (up 893.71% YoY), while the FY2025 annual figure was -$902000.0, down 34.03% from the prior year.
- Other Working Capital Changes was $6.5 million for Q1 2026 at Zenas BioPharma, up from -$245000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.5 million in Q1 2026 to a low of -$580000.0 in Q2 2025.
- Historically, Other Working Capital Changes has averaged $475600.0 across 4 years, with a median of -$167000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes slumped 311.35% in 2025, then soared 3019.82% in 2026.
- A 4-year view of Other Working Capital Changes shows it stood at -$151000.0 in 2023, then tumbled by 31.13% to -$198000.0 in 2024, then dropped by 23.74% to -$245000.0 in 2025, then soared by 2745.71% to $6.5 million in 2026.
- The last three Other Working Capital Changes figures came in at $6.5 million (Q1 2026), -$245000.0 (Q4 2025), and $145000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.48 Mn |
| Mar 31, 2026 | 6.48 Mn |
| Dec 31, 2025 | -245,000.00 |
| Dec 31, 2025 | -245,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | -580,000.00 |
| Jun 30, 2025 | -580,000.00 |
| Mar 31, 2025 | -222,000.00 |
| Mar 31, 2025 | -222,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Sep 30, 2024 | -170,000.00 |
| Sep 30, 2024 | -170,000.00 |
| Jun 30, 2024 | -141,000.00 |
| Jun 30, 2024 | -141,000.00 |
| Mar 31, 2024 | -164,000.00 |
| Mar 31, 2024 | -164,000.00 |
| Dec 31, 2023 | -151,000.00 |
| Dec 31, 2023 | -151,000.00 |